Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: PrEP.
- Who it may be relevant to
- Registry conditions: HIV Prevention. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Thailand
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Thai Red Cross AIDS Research Centre (TRC-ARC)
Overview
PrEP-30 is a demonstration project to assess the feasibility of providing oral PrEP to MSM and other individuals at-risk for HIV in Bangkok, Thailand as a service that is funded entirely through user fees. Tenofovir disoproxil fumarate/emtricitabine PrEP is provided part of a combined HIV prevention program that includes risk-reduction counseling, regular HIV testing, and the provision of condoms and lubricants. PrEP-30 is implemented at the Thai Red Cross AIDS Research Centre, at the site of the largest HIV counseling and testing center in Thailand.
Interventions
- Drug PrEP
Oral pre-exposure prophylaxis (PrEP) for HIV infection using a daily combination tablet of tenofovir disoproxil fumarate and emtricitabine
Primary outcome measures
- Primary outcome measures: [Time frame: 12 months]
Eligibility criteria
Inclusion criteria
- Age > 18 years
- HIV test negative
- Creatinine clearance > 60 ml/min
- No contraindication or allergy to PrEP medications (TDF/FTC)
- At least one risk factor for HIV infection within the previous 6 months:
- sex partner known to be HIV positive
- works as commercial sex worker
- use of PEP for sexual exposure
- injection drug use
- any STI (syphilis, gonorrhea, chlamydia)
- > 5 sex partners
- inconsistent condom use with high-risk partners, including MSM, IDU
- MSM: any insertive or receptive anal sex without condom
- Women: any sex without condom with high-risk male partner (MSM, IDU, multiple female partners)
- Heterosexual men: any sex without condom with high-risk female partner (commercial sex worker, IDU, multiple male partners)
Exclusion Criteria: -
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Thailand · 1 center
- Thai Red Cross AIDS Research Centre — Bangkok
Identifiers
NCT: NCT02437981 · PrEP-30 demonstration project